Drugs for neglected diseases new incentives for innovation

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Pharmaceutical innovation
1. Verfasser:	Hollis, Aidan (VerfasserIn)
Format:	UnknownFormat
Sprache:	eng
Veröffentlicht:	2007
Schlagworte:	Aufsatz im Buch
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Titel	Jahr	Verfasser
Competition between generic and branded drugs	2007	Grabowski, Henry G.
The pharmaceutical sector in health care	2007	Reinhardt, Uwe E.
When patents fail : finding new drugs for the developing world	2007	Maurer, Stephen M.
Implementing a public subsidy for vaccines	2007	Sloan, Frank A.
Ensuring the future supply of vaccines : is a national vaccine authority the answer?	2007	Lichtenberg, Frank R.
Pharmaceutical spending and health outcomes	2007
Pharmaceutical innovation and health outcomes : empirical evidence from Taiwan	2007
Conclusions and policy implications	2007	Sloan, Frank A.
The economics of research and development in the pharmaceutical industry	2007	Comanor, William S.
Drugs for neglected diseases : new incentives for innovation	2007	Hollis, Aidan
Measures of costs and benefits for drugs in cost-effectiveness analysis	2007	Pauly, Mark V.
The United States' experience with direct-to-consumer advertising of prescription drugs : what have we learned?	2007	Berndt, Ernst R.
Using economic evaluation in reimbursement decisions for health technologies : lessons from international experience	2007	Drummond, Michael F.